Video: Every Case Tells a Story| Webinar: ACR/CHEST ILD Guidelines in Practice

An official publication of the ACR and the ARP serving rheumatologists and rheumatology professionals

  • Conditions
    • Axial Spondyloarthritis
    • Gout and Crystalline Arthritis
    • Myositis
    • Osteoarthritis and Bone Disorders
    • Pain Syndromes
    • Pediatric Conditions
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Sjögren’s Disease
    • Systemic Lupus Erythematosus
    • Systemic Sclerosis
    • Vasculitis
    • Other Rheumatic Conditions
  • FocusRheum
    • ANCA-Associated Vasculitis
    • Axial Spondyloarthritis
    • Gout
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Systemic Lupus Erythematosus
  • Guidance
    • Clinical Criteria/Guidelines
    • Ethics
    • Legal Updates
    • Legislation & Advocacy
    • Meeting Reports
      • ACR Convergence
      • Other ACR meetings
      • EULAR/Other
    • Research Rheum
  • Drug Updates
    • Analgesics
    • Biologics/DMARDs
  • Practice Support
    • Billing/Coding
    • EMRs
    • Facility
    • Insurance
    • QA/QI
    • Technology
    • Workforce
  • Opinion
    • Patient Perspective
    • Profiles
    • Rheuminations
      • Video
    • Speak Out Rheum
  • Career
    • ACR ExamRheum
    • Awards
    • Career Development
  • ACR
    • ACR Home
    • ACR Convergence
    • ACR Guidelines
    • Journals
      • ACR Open Rheumatology
      • Arthritis & Rheumatology
      • Arthritis Care & Research
    • From the College
    • Events/CME
    • President’s Perspective
  • Search

Search results for: rituximab

Case Report: Uncommon Complications in ANCA-Associated Vasculitis

Logan Oliver, MD, & Jason J. Weiner, MD, FACP, FACR  |  December 9, 2024

Anti-neutrophil cytoplasmic antibody (ANCA) associated vasculitis is a rare autoimmune condition characterized by inflammation of small- and medium-sized vessels. ANCA-associated vasculitis can lead to multisystem organ complications, including life-threatening pulmonary hemorrhage, renal failure and death. We present a case of ANCA-associated vasculitis complicated by complement-mediated thrombotic microangiopathy (c-TMA). Of the rheumatic diseases, systemic lupus erythematosus…

Filed under:ConditionsVasculitis Tagged with:ANCA-Associated Vasculitisc-TMAcase reportcomplement-mediated thrombotic microangiopathy (c-TMA)Fellows Forum

Top Research in Rheumatoid Arthritis Presented at ACR Convergence 2024

Jeffrey Curtis, MD, MS, MPH  |  December 3, 2024

Why this research is relevant to clinicians today & researchers in the future WASHINGTON, D.C.—The ACR Convergence 2024 meeting in Washington, D.C., reflected the continued advancement of science and practical research in the field of rheumatoid arthritis. Highlights this year centered on new RA treatments and new uses of existing treatments; the use of artificial…

Filed under:ACR ConvergenceConditionsGuidanceMeeting ReportsRheumatoid Arthritis Tagged with:ACR Convergence 2024ACR Convergence 2024 RA

Where Are We with RA? Prevention, Treatment & Management Challenges

Samantha C. Shapiro, MD  |  December 3, 2024

In this Review Course at ACR Convergence 2024, Iain McInnes, PhD, FRCP, discussed some of the challenges of RA: Remission is drug maintained, multimorbidity abounds, treatment strategies can be complex, & prevention is not yet possible.

Filed under:ACR ConvergenceConditionsRheumatoid Arthritis Tagged with:ACR Convergence 2024ACR Convergence 2024 RA

Precision Medicine Benefits Patients with Systemic Sclerosis

Jason Liebowitz, MD, FACR  |  November 26, 2024

Experts provided insights into how precision medicine is being used to address the needs and care of patients with systemic sclerosis.

Filed under:ACR ConvergenceConditionsMeeting ReportsSystemic Sclerosis Tagged with:ACR Convergence 2024ILDinterstitial lung disease (ILD)Precision MedicineSclerodermascleroderma-associated ILDskinSSc-ILDsystemic sclerosis (SSc)

Collaborative Care Essential for Diagnosis & Care of Neurosarcoidosis

Ruth Jessen Hickman, MD  |  November 26, 2024

At a ACR Convergence 2024 session, experts discussed key characteristics, diagnostic challenges & treatment considerations for neurosarcoidosis.

Filed under:ACR ConvergenceConditionsMeeting ReportsMeeting ReportsOther Rheumatic Conditions Tagged with:ACR Convergence 2024Sarcoidosis

AC&R Study Summary: Standardizing Treatment for Moderately Severe JDM

By Matthew A. Sherman, MD, MHSc, & Stacey E. Tarvin, MD, MS  |  November 10, 2024

Why was this study done? Juvenile dermatomyositis (JDM) is the most common type of idiopathic inflammatory myopathy in childhood, and most patients have a chronic disease course requiring prolonged administration of systemic glucocorticoids and immunosuppressive agents. The initial management for patients with moderately severe JDM is relatively standardized, typically including methotrexate and systemic glucocorticoids with…

Filed under:Biologics/DMARDsConditionsDrug UpdatesGuidelinesMyositisResearch ReviewsResearch Rheum Tagged with:juvenile dermatomyositisReading Rheum

2024 Research Updates in ANCA-Associated & IgA Vasculitis

Philip Seo, MD, MHS  |  October 7, 2024

Summaries of selected research abstracts on ANCA-associated vasculitis & IgA vasculitis from the International Vasculitis Workshop. 

Filed under:Biologics/DMARDsConditionsDrug UpdatesMeeting ReportsResearch ReviewsResearch RheumVasculitis Tagged with:AAVAAV FocusRheumabataceptANCA-Associated VasculitisbenralizumabhypogammaglobulinemiaIgA vasculitismepolizumabrituximab

Meet the 2024 Lupus Insight Prize Honorees

Gretchen Henkel  |  October 7, 2024

Marko Radic, PhD, & Georg Schett, MD, were awarded the 2024 Lupus Insight Prize for advances in CAR-T cell therapy. 

Filed under:AwardsConditionsSystemic Lupus Erythematosus Tagged with:Dr. Georg SchettDr. Marko Z. RadicLupus Insight PrizeLupus Research AllianceSLE Resource Center

Spotlight on Pediatric Rheumatology in Singapore

Jason Liebowitz, MD, FACR  |  September 26, 2024

A pioneer of pediatric rheumatology in Singapore, Dr. Elizabeth Ang details her unique clinical experiences.

Filed under:ConditionsEULAR/OtherGuidanceMeeting ReportsPediatric Conditions Tagged with:ACR/APLAR ExchangeAPLAR 2024

Affiliate Society Council Active & Reenergized, Reports Chair Gwenesta B. Melton, MD

Gretchen Henkel  |  September 21, 2024

ASC Chair Gwenesta B. Melton, MD, shares the connections and activities that are helping the council develop stronger ties in and outside the ACR.

Filed under:Legislation & AdvocacyProfessional Topics Tagged with:Affiliate Society Council (ASC)Association of Women in Rheumatology (AWIR)Coalition of State Rheumatology Organizations (CSRO)

  • « Previous Page
  • 1
  • …
  • 3
  • 4
  • 5
  • 6
  • 7
  • …
  • 44
  • Next Page »
  • About Us
  • Meet the Editors
  • Issue Archives
  • Contribute
  • Advertise
  • Contact Us
  • Copyright © 2025 by John Wiley & Sons, Inc. All rights reserved, including rights for text and data mining and training of artificial technologies or similar technologies. ISSN 1931-3268 (print). ISSN 1931-3209 (online).
  • DEI Statement
  • Privacy Policy
  • Terms of Use
  • Cookie Preferences